StockNews.com Begins Coverage on Aspira Women’s Health (NASDAQ:AWH)

StockNews.com started coverage on shares of Aspira Women’s Health (NASDAQ:AWH) in a report issued on Tuesday. The brokerage set a “hold” rating on the stock.

Aspira Women’s Health Stock Up 0.3 %

Shares of AWH stock opened at $0.71 on Tuesday. Aspira Women’s Health has a 52 week low of $0.67 and a 52 week high of $5.65. The firm has a market capitalization of $11.75 million, a price-to-earnings ratio of -0.59 and a beta of 1.39. The stock has a fifty day moving average of $0.80 and a 200 day moving average of $1.00.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Aspira Women’s Health stock. Pine Valley Investments Ltd Liability Co bought a new stake in shares of Aspira Women’s Health Inc. (NASDAQ:AWH) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 31,200 shares of the company’s stock, valued at approximately $25,000. Pine Valley Investments Ltd Liability Co owned 0.19% of Aspira Women’s Health at the end of the most recent quarter. Institutional investors own 12.19% of the company’s stock.

Aspira Women’s Health Company Profile

Aspira Women's Health Inc, together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States. The company's products include Ova1Plus, a qualitative serum test to assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker test intended to maintain Ova1's high sensitivity; and OvaWatch, a laboratory developed tests to assist in the initial clinical assessment of malignancy risk in all women thought to have an indeterminate or benign adnexal mass.